Stenotrophomonas maltophilia is an important multidrug resistant nosocomial pathogen. Trimethoprim/sulfamethoxazole (TMP/SMX) is considered the drug of choice for treatment of S. maltophilia infections, thus emerging resistance to TMP/SMX poses a serious threat. In the present study we aimed to investigate the frequency of TMP/SMX resistance genes (sul1, sul2, dfrA), and to evaluate their relatedness with integron 1 (int1), and insertion sequence common regions (ISCR) among 100 S. maltophilia from different clinical isolates in Egypt. Isolates were identified biochemically and confirmed by VITEK2. Detection of sul1, sul2, and dfrA genes, int1 and ISCR elements was performed by PCR. Among the 16 TMP/SMX resistant isolates, sul1 gene was detected in all of them, and it was associated with int1 gene presence in all resistant isolates. The sul2 gene was detected in 6 out of 16 resistant isolates (37.5%), and only 2 of the 16 resistant isolates (12.5%) harboured dfrA gene. ISCR was detected in 10 of the resistant isolates (62.5%) and in 4 of them it was associated with the presence of sul2 gene. Among the 84 TMP/SMX sensitive isolates, sul1 gene was detected in 15 (17.8%), int1 in 16 (19%) and ISCR in 6 (7.1%). None of the susceptible isolates had sul2 or dfrA genes. These findings point out an increasing frequency of TMP/SMX resistance genes among S. maltophilia clinical isolates in our region, so the adoption of prudent use of S. maltophilia antimicrobial agents and the establishment of a surveillance system are desperately needed.
Brooke JS . Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev 2012; 25: 2e41.
Looney WJ , Narita M , Mühlemann K . Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 2009; 9: 312–323.
Abbott IJ , Slavin MA , Turnidge JD , Thursky KA , Worth LJ . Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment. Expert Rev Anti Infect Ther 2011; 9(4): 471–488.
Chang YT , Lin CY , Chen YH , Hsueh PR . Update on infections caused by stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front Microbiol 2015; 6: 893–912.
Nicodemo AC , Paez JI . Antimicrobial therapy for stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis 2007; 26: 229e37.
Brooke JS . New strategies against stenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen. Expert Rev Anti Infect Ther 2014; 12: 1e4.
Al-Jasser AM . Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem. Ann Clin Microbiol Antimicrob 2006; 5: 23.
Toleman MA , Bennett PM , Bennett DM , Jones RN , Walsh TR . Global emergence of trimethoprim/sulfamethoxazole resistance in stenotrophomonas maltophilia mediated by acquisition of sul genes. Emerg Infect Dis 2007; 13: 559–565.
Hu LF , Chen GS , Kong QX , Gao LP , Chen X , Ye Y , Li JB . Increase in the Prevalence of resistance determinants to trimethoprim/sulfamethoxazole in clinical stenotrophomonas maltophilia Isolates in China. PLoS One 2016; 11(6): e0157693.
Chung HS , Kim K , Hong SS , Hong SG , Lee K , Chong Y . The sul1 gene in stenotrophomonas maltophilia with high-level resistance to trimethoprim/sulfamethoxazole. Ann Lab Med 2015; 35(2): 246–249.
Hu LF , Chang X , Ye Y , Wang ZX , Shao YB , Shi W , Li X , Li JB . Stenotrophomonas maltophilia resistance to trimethoprim/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron. Int J Antimicrob Agents 2011; 37(3): 230–234.
Clinical and Laboratory Standards Institute (CLSI) . Performance standards for antimicrobial susceptibility testing, (29th.), 2019.
Ahmed, O.B. ; Dablool, A.S. Quality improvement of DNA extracted by boiling method in Gram negative bacteria. Int. J. Bioassays 2017; 6: 5347–5349.
Baumrin E , Piette EW , Micheletti RG . Stenotrophomonas maltophilia: an emerging multidrug-resistant opportunistic pathogen in the immunocompromised host. BMJ Case Rep 2017; 2017: bcr2017221053.
Wang CH , Lin JC , Chang FY , Yu CM , Lin WS , Yeh KM . Risk factors for hospital acquisition of trimethoprim-sulfamethoxazole resistant stenotrophomonas maltophilia in adults: a matched case-control study. J Microbiol Immunol Infect 2017; 50(5): 646–652.
Çıkman A , Parlak M , Bayram Y , Güdücüoğlu H , Berktaş M . Antibiotics resistance of stenotrophomonas maltophilia strains isolated from various clinical specimens. Afr Health Sci 2016; 16(1): 149–152.
Bostanghadiri N , Ghalavand Z , Fallah F , Yadegar A , Ardebili A , Tarashi S , Pournajaf A , Mardaneh J , Shams S , Hashemi A . Characterization of phenotypic and genotypic diversity of stenotrophomonas maltophilia strains isolated from selected hospitals in Iran. Front Microbiol 2019; 10: 1191.
Kaur P , Gautam V , Tewari R . Distribution of class 1 integrons, sul1 and sul2 genes among clinical isolates of stenotrophomonas maltophilia from a tertiary care hospital in North India. Microb Drug Resist 2015; 21(4): 380–385.
Ebrahim-Saraie HS , Heidari H , Soltani B , Mardaneh J , Motamedifar M . Prevalence of antibiotic resistance and integrons, sul and Smqnr genes in clinical isolates of stenotrophomonas maltophilia from a tertiary care hospital in southwest Iran. Iran J Basic Med Sci 2019; 22(8): 872–877.
Youenou B , Favre-Bonté S , Bodilis J , Brothier E , Dubost A , Muller D , Nazaret S . Comparative genomics of environmental and clinical stenotrophomonas maltophilia strains with different antibiotic resistance profiles. Genome Biol Evol 2015; 7(9): 2484–2505.
Neela V , Rankouhi SZ , van Belkum A , Goering RV , Awang R . Stenotrophomonas maltophilia in Malaysia: molecular epidemiology and trimethoprim-sulfamethoxazole resistance. Int J Infect Dis 2012; 16(8): e603–e607.
Singhal L , Kaur P , Gautam V . Stenotrophomonas maltophilia: from trivial to grievous. Indian J Med Microbiol 2017; 35(4): 469–479.
Chung HS , Hong SG , Kim YR , Shin KS , Whang DH , Ahn JY , Park YJ , Uh Y , Chang CL , Shin JH , Lee HS , Lee K , Chong Y . Antimicrobial susceptibility of stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates. J Korean Med Sci 2013; 28(1): 62–66.
Malekan M , Tabaraie B , Akhoundtabar L , Afrough P , Behrouzi A . Distribution of class I integron and smqnr resistance gene among stenotrophomonas maltophilia isolated from clinical samples in Iran. Avicenna J Med Biotechnol 2017; 9(3): 138–141.
Grape M , Farra A , Kronvall G , Sundström L . Integrons and gene cassettes in clinical isolates of co-trimoxazole-resistant Gram-negative bacteria. Clin Microbiol Infect 2005; 11(3): 185–192.
Song JH , Sung JY , Kwon KC , Park JW , Cho HH , Shin SY , Ko YH , Kim JM , Shin KS , Koo SH . Analysis of acquired resistance genes in stenotrophomonas maltophilia. Korean J Lab Med 2010; 30(3): 295–300.